Efficacy of radiotherapy in combination with first-line immunotherapy and chemotherapy for advanced lung squamous cell carcinoma: a propensity score analysis.

Front Immunol · 2023 · PMC10227428 · PMID 37261356

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Radiotherapy showed a trend of having greater clinical benefits in the PD-L1-positive subgroup than in the PD-L1-negative subgroup, even though half of the patients’ PD-L1 statuses were unknown.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.